From: Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
Target | HR | 95% CI | P value | FDR | Affiliation |
---|---|---|---|---|---|
SHMT2 | 1.88 | 1.50–2.36 | <0.001 | <0.001 | Serine metabolism |
ASCT2 | 1.83 | 1.45–2.31 | <0.001 | <0.001 | Glutamine metabolism |
GAPDH | 1.52 | 1.19–1.94 | <0.001 | 0.009 | Glucose metabolism |
FH | 1.65 | 1.20–2.27 | 0.002 | 0.019 | TCA cycle |
CAD | 2.07 | 1.29–3.33 | 0.003 | 0.019 | Pyrimidine metabolism |
PKM2 | 1.46 | 1.13–1.88 | 0.003 | 0.02 | Glucose metabolism |